Drug Profile
Aceclofenac/diacerein/glucosamine - Jenburkt Pharmaceuticals
Alternative Names: Diacerein/aceclofenac/glucosamine; Glucosamine/aceclofenac/diacereinLatest Information Update: 19 Feb 2016
Price :
$50
*
At a glance
- Originator Jenburkt Pharmaceuticals
- Class Analgesics; Anthraquinones; Anti-inflammatories; Antirheumatics; Carbohydrates; Disease-modifying antirheumatics; Esters; Hexosamines; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Peripheral nervous system agents; Phenylacetates; Sensory system agents; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Interleukin 1 receptor antagonists; Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 19 Feb 2016 No development reported - Phase-III for Osteoarthritis in India (PO)
- 05 Feb 2013 Jenburkt Pharmaceuticals completes a phase III trial in Osteoarthritis in India (CTRI2010-091-001092)
- 15 Jul 2010 Phase-III clinical trials in Osteoarthritis in India (PO)